These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 20696761

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Kv1 potassium channels control action potential firing of putative GABAergic deep cerebellar nuclear neurons.
    Feria Pliego JA, Pedroarena CM.
    Sci Rep; 2020 Apr 24; 10(1):6954. PubMed ID: 32332769
    [Abstract] [Full Text] [Related]

  • 4. A Novel KCNA2 Variant in a Patient with Non-Progressive Congenital Ataxia and Epilepsy: Functional Characterization and Sensitivity to 4-Aminopyridine.
    Imbrici P, Conte E, Blunck R, Stregapede F, Liantonio A, Tosi M, D'Adamo MC, De Luca A, Brankovic V, Zanni G.
    Int J Mol Sci; 2021 Sep 14; 22(18):. PubMed ID: 34576077
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Kcna1-mutant rats dominantly display myokymia, neuromyotonia and spontaneous epileptic seizures.
    Ishida S, Sakamoto Y, Nishio T, Baulac S, Kuwamura M, Ohno Y, Takizawa A, Kaneko S, Serikawa T, Mashimo T.
    Brain Res; 2012 Jan 30; 1435():154-66. PubMed ID: 22206926
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. An activator of voltage-gated K+ channels Kv1.1 as a therapeutic candidate for episodic ataxia type 1.
    Servettini I, Talani G, Megaro A, Setzu MD, Biggio F, Briffa M, Guglielmi L, Savalli N, Binda F, Delicata F, Bru-Mercier G, Vassallo N, Maglione V, Cauchi RJ, Di Pardo A, Collu M, Imbrici P, Catacuzzeno L, D'Adamo MC, Olcese R, Pessia M.
    Proc Natl Acad Sci U S A; 2023 Aug 30; 120(31):e2207978120. PubMed ID: 37487086
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical and Functional Study of a De Novo Variant in the PVP Motif of Kv1.1 Channel Associated with Epilepsy, Developmental Delay and Ataxia.
    Dinoi G, Morin M, Conte E, Mor Shaked H, Coppola MA, D'Adamo MC, Elpeleg O, Liantonio A, Hartmann I, De Luca A, Blunck R, Russo A, Imbrici P.
    Int J Mol Sci; 2022 Jul 22; 23(15):. PubMed ID: 35897654
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Episodic ataxia type 1 mutations affect fast inactivation of K+ channels by a reduction in either subunit surface expression or affinity for inactivation domain.
    Imbrici P, D'Adamo MC, Grottesi A, Biscarini A, Pessia M.
    Am J Physiol Cell Physiol; 2011 Jun 22; 300(6):C1314-22. PubMed ID: 21307345
    [Abstract] [Full Text] [Related]

  • 19. Ataxia and myoclonic epilepsy due to a heterozygous new mutation in KCNA2: proposal for a new channelopathy.
    Pena SD, Coimbra RL.
    Clin Genet; 2015 Feb 22; 87(2):e1-3. PubMed ID: 25477152
    [Abstract] [Full Text] [Related]

  • 20. Episodic ataxia type 1 mutations in the KCNA1 gene impair the fast inactivation properties of the human potassium channels Kv1.4-1.1/Kvbeta1.1 and Kv1.4-1.1/Kvbeta1.2.
    Imbrici P, D'Adamo MC, Kullmann DM, Pessia M.
    Eur J Neurosci; 2006 Dec 22; 24(11):3073-83. PubMed ID: 17156368
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.